Nl-Fr

View abstract

This abstract is assigned to session AOB Free Papers 2
Presentation typeOral presentation
TitleComparative study of PRESERFLOTM MicroShunt, XEN45® Gel Stent and Trabeculectomy in open-angle glaucoma
PurposeTo compare the safety and efficacy of PRESERFLOTM MicroShunt (MS), trabeculectomy (Trab) and XEN45® Gel Stent (XEN) in patients with open-angle glaucoma during the first year.
MethodsA single-centre retrospective case-control study was conducted on all eyes that underwent standalone glaucoma surgery between 2013 and 2020.

The primary outcome was surgical success after 1 year. Complete success was defined as intraocular pressure (IOP) of 6–15 mmHg or 6–18 mmHg, without vision loss, additional glaucoma surgery, or IOP-lowering medication. Qualified success allowed medication and/or laser therapy. Secondary outcomes included visual acuity, medication use, and complications.
ResultsIn total, 384 eyes of 384 patients were included, 82 eyes received a MS, 117 a Trab and 185 a XEN. MS achieved the highest rates of both complete and qualified success across both IOP criteria. Regarding complete success, MS was equal to Trab (p=0.207, IOP 6-15mmHg and p=0.230, IOP 6-18). MS (p<0,001) and Trab (p=0.030 and p=0.018, respectively) performed significantly better than XEN. For qualified success, MS showed superior outcomes, with statistical significance only observed comparing MS to XEN in the IOP 6-18 mmHg group (p=0.049).
Significant hypotony was rare across groups and peaked in the first week. Minor interventions were more frequent after Trab.
ConclusionMS and Trab achieved comparable success rates and outperformed XEN without use of medication. MS demonstrated superior efficacy over XEN regardless of medication use. MS and Xen need fewer post-operative interventions compared to Trab.
Conflict of interestYes
Details of conflicting interestsI. S. received a research grant from AbbVie and Santen.
Authors 1
InitialsMI
Last nameBillen
DepartmentUZL/KUL
CityLeuven
Authors 2
InitialsT
Last nameJacobs
DepartmentUZL/KUL
CityLeuven
Authors 3
InitialsJ
Last nameVan Eijgen
DepartmentUZL/KUL
CityLeuven
Authors 4
InitialsS
Last nameLemmens
DepartmentUZL/KUL
CityLeuven
Authors 5
InitialsE
Last nameVandewalle
DepartmentUZL/KUL
CityLeuven
Authors 6
InitialsI
Last nameStalmans
DepartmentUZL/KUL
CityLeuven
top ^